JORNAY PM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Jornay Pm, and what generic alternatives are available?
Jornay Pm is a drug marketed by Ironshore Pharms and is included in one NDA. There are fifteen patents protecting this drug.
This drug has thirty-seven patent family members in fourteen countries.
The generic ingredient in JORNAY PM is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Jornay Pm
A generic version of JORNAY PM was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
Summary for JORNAY PM
International Patents: | 37 |
US Patents: | 15 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Patent Applications: | 3,544 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for JORNAY PM |
What excipients (inactive ingredients) are in JORNAY PM? | JORNAY PM excipients list |
DailyMed Link: | JORNAY PM at DailyMed |
Pharmacology for JORNAY PM
Drug Class | Central Nervous System Stimulant |
Physiological Effect | Central Nervous System Stimulation |
Anatomical Therapeutic Chemical (ATC) Classes for JORNAY PM
US Patents and Regulatory Information for JORNAY PM
JORNAY PM is protected by fifteen US patents.
Patents protecting JORNAY PM
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods of treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods and compositions for treatment of attention deficit disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Methods for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods of treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-005 | Aug 8, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-003 | Aug 8, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-003 | Aug 8, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-004 | Aug 8, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for JORNAY PM
See the table below for patents covering JORNAY PM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 6043785 | ⤷ Try a Trial | |
Japan | 2017128614 | 注意欠陥障害の処置のための方法および組成物 (METHODS AND COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT DISORDER) | ⤷ Try a Trial |
Japan | 2020079322 | 注意欠陥障害の処置のための方法および組成物 (METHODS AND COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT DISORDER) | ⤷ Try a Trial |
Spain | 2883589 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |